ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000235.1|Kiamycin_1 # 1 # 750 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000235.1|Kiamycin_1 	1	750	+	Loose	650	95.9005	tetA(58)	32.24	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCCTGCTGCTCGACCGCGTCACCTTCCGCTACCGCCGCTGGGAACGCCCCGTCCTCTCCGGCTTCAGCTACGAGGTCCCCGACGAGGGCCTGACGATCCTGCTCGGCCCCAACGGAGCGGGCAAGTCGACCACGATGTCCCTCCTGGCGGGCACGGTGGAGCCCCAGGGTGGCAAGGTCCGGCTCAAGGACTCCACTCTCACCTCCGCCGCCCGCGCGTACCGCCGGCATGTGGCGTGGCTGCCGCAGAAGGTACCGACGTCACGGCAGCTGACCGCCCGCGAGTACGTGGCGTACGTGGCCTGGCTGAAGGGCGAGGACCGTACGGGAGCCTGGGAGCGCGCTGGGAAGGCCCTCGACCAGGTGGGCCTCGCCGAGCAGAGCGGCCGGAAGACGGCCAAGCTCTCCGGAGGCCAGCTCCGTCGGGTCGGCATCGCGTGCGCGCTGGCCCACGACGCGCAGGTGATCCTCCTCGACGAGCCCACGGCCGGACTCGACCCGCACCAGCGCACCGTCTTCCGAAACGTGCTGCGCACGGTCGCCGACCGCATTCCGGTCTTGATGTCCACCCACGACATCGCCGACCTGGCCGACGAGGCGAACACCGTCTCCCTCATGGACCGCGGCCGGGTCCTCCACCACGGAGCGACCCGGAGCTTCCTGGACCAGGCGCGGTCCGACGCCGCTCCTGGCCGGCAGGCCGAGTCCGCGTACGCCGTCCTCATGGGTCTGGAGAGCACCGGATAA	MTLLLDRVTFRYRRWERPVLSGFSYEVPDEGLTILLGPNGAGKSTTMSLLAGTVEPQGGKVRLKDSTLTSAARAYRRHVAWLPQKVPTSRQLTAREYVAYVAWLKGEDRTGAWERAGKALDQVGLAEQSGRKTAKLSGGQLRRVGIACALAHDAQVILLDEPTAGLDPHQRTVFRNVLRTVADRIPVLMSTHDIADLADEANTVSLMDRGRVLHHGATRSFLDQARSDAAPGRQAESAYAVLMGLESTG	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	72.59	gnl|BL_ORD_ID|2243|hsp_num:0	2517			141	690	tetracycline
BGC0000235.1|Kiamycin_3 # 1747 # 2187 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.717	BGC0000235.1|Kiamycin_3 	1747	2187	+	Loose	700	26.5646	ACT-54	25.26	3006249	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGCCCGGGACGGCTTCCAGCACCACGCCCGGGACGACGACGGCAGCGCTGCGCGGCGCGGTCGAGGCGTACTGGACGGCGGCCGAGGCGCGCGACTGGAGCGCGTTCGGTGCGACCCTCGCCGAGGGCGTGGTGTACGACCTGCCGCAGACGCGGGAGCGGATCCTCGGCAAGGAGCGGTATCTCCGGTTCAACCAGGAGTATCCGGGCGACTGGCACGTCCGGGTCGAGCGGATCGTCGCCGACGCCGAGGGCCGGCAGGCCGCCGCCCGTACCGGCTTCACCGTGACGGGCGATCAGCCGGAGGAGCAGCCGCAGGAGTTGGACGCCATCCACTTCTTCACGTTCGACGAGGAGGGGCTGATCACCGGGGTGACGGACTTCTGGCCCGAGTCGTACGAGCCTCCGGCCGGCCGCGAGCACCTGGTCGAGCGCTACTGA	MPGTASSTTPGTTTAALRGAVEAYWTAAEARDWSAFGATLAEGVVYDLPQTRERILGKERYLRFNQEYPGDWHVRVERIVADAEGRQAAARTGFTVTGDQPEEQPQELDAIHFFTFDEEGLITGVTDFWPESYEPPAGREHLVERY	MMKKSLCCALLLSTSCAALAAPMSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHYFTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGALAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKSEEQHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVKDMASWVMANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKSYPNPARVEAAYRILSALQ	38.32	gnl|BL_ORD_ID|3107|hsp_num:0	4145			675	942	
BGC0000235.1|Kiamycin_4 # 2248 # 3054 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.693	BGC0000235.1|Kiamycin_4 	2248	3054	-	Loose	1100	25.409	tetA(60)	31.82	3004035	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTCAGTACGCAGAATTCGTGCATCCGTCGTCACTCTCGCGCTCGCCGCCGTGGCCGCGCTCGGCGCCGCGGGGCCGGCCTCCGCGGCCGACTCGGCCGCCGCGGGCGGCTATGTCGCGCTCGGCGACTCCTACTCCTCGGGCGTCGGCGCCGGAAGCTACCTTTCCGACAGCGGCGACTGCCGGCGCAGCACCAACGCCTACCCGTATCTGTGGCAGGCGGCCAACTCCCCCGCCTCGTTCGACTTCGTCGCCTGTTCGGGAGCGACCACCTCGTCCGTGGCCAGCAGCCAGCTCGGGGCGCTCAGCGCGTCCACCTCCCTGGTCAGCGTCACCGCCGGAGGCAATGACGTCGGGTTCGCCGACGTCATGCAGGACTGCGTGCTGTCGGGCGAGGCCACCTGCATCAACAGCGTGAACAACGCCGTCTCGCAAATGAACAACTCCCTGCCCGGCAGCCTCGATTCGCTCTACGACGGCATCCGGGCCCGCGCGCCGCAGGCCCAGGTCGTGGTTCTCGGCTACCCGCGCTTCTACAAGCTGGCCGGCAGCTGCTTCGCCGGTCTCAGTGAGGCCGAACGGTCCGCGATCAACAACGCGTCGGACGTTCTGAACGACGTCATCGCCAAGCGGTCCGCCGACGCCGGGTTCACCTTCTCCAGCGTGGTCGACGAGTTCACCGGGCACGAGCTGTGCTCCGGCGACGCCTGGCTCCACAGCGTATCGGTGCCGATCTACAACTCGTATCACCCCAAGGCCGCGGGGCAGTCGGGCGGCTATCTGCCCGCCTTCCGCTCGGCCGTGTAG	MSVRRIRASVVTLALAAVAALGAAGPASAADSAAAGGYVALGDSYSSGVGAGSYLSDSGDCRRSTNAYPYLWQAANSPASFDFVACSGATTSSVASSQLGALSASTSLVSVTAGGNDVGFADVMQDCVLSGEATCINSVNNAVSQMNNSLPGSLDSLYDGIRARAPQAQVVVLGYPRFYKLAGSCFAGLSEAERSAINNASDVLNDVIAKRSADAGFTFSSVVDEFTGHELCSGDAWLHSVSVPIYNSYHPKAAGQSGGYLPAFRSAV	MNDLLKVIINFIKKHPMRYLVSFILMIGSSIAAVYPARIIGQVVDKIVASELNAEWLGTQLVILVGIILVAYITESIWTYFIFIGYYEIQKELRVKLLRNNLRKKIPFYAHFRTGEIITRSSEDVTTIGDMMGFGMFALMNSTLLMSVSIYMMVTTISLPLTIAAILPLPILSYLVYKWGFDLEEEYNKAQNAVSQLNNEVLEMIDGTYVIRAYGQEDAMMDEFRAKTKKAMKQNIIVTEIESRFIPLAQLFMMISFTIALFYGGYLVSTGAILVGDVIAFQVYMGAIMWPMFMIGDIITNYKRGKVATERINEVLKHDDEIERGGTKTLETIESIEFKDFHFMYPGEEAPLLKEINLTLRKGETLGIVGKTGSGKTTLLMQLLHQFPYRGEKLLINGEPLIDYDTQSVAGHLAYVPQEHTLFSRTIRENMLFGKEDATDDEIWEALTLASFEGDVKRMPDELDTMVGEKGVSLSGGQKQRLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQERGGCMNIISAHRLSAIRHADEIIVMNEGRISERGTHEELLEQRGWYYEQYLTQEMEEEIE	46.29	gnl|BL_ORD_ID|2310|hsp_num:0	2645			561	693	tetracycline
BGC0000235.1|Kiamycin_6 # 4715 # 4906 # -1 # ID=1_6;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.661	BGC0000235.1|Kiamycin_6 	4715	4906	-	Loose	500	21.557	mphG	50.0	3003742	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	TTGGCAACTGCCTTCATATCGTCGCCGCACTACCCGGCCACCCCCACACCGCCCGCCCGGAGCCGTGCCACAAATCCGACGACGGAGAAGGCGATTGACGCAAACAGGCGAGAATTGACACCTGAGAGTGTCCGGGTTCTGCGGCCCCGGCCCGAGAGGACGGCGACCGGGGCCCGTCGAAGCATGGCGTGA	MATAFISSPHYPATPTPPARSRATNPTTEKAIDANRRELTPESVRVLRPRPERTATGARRSMA	MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPRRTTLGEQIANEKRILQLVSKYLSVQVPDWRIANEKLVAYPLLDGKPALTYDAETYEVTWNMSKENDLYIPSLAKALIELHSIPTEEVLRNNLKILTPEQVRNEISERLILVKSELGINAELELRYQKWLDNDALWPNFTKFIHGDLYAGHTLTHHNGEVCGIIDWSTAQVSDIAQDFSGHVTVFGEESLKNLIAAYEKQGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGVE	21.43	gnl|BL_ORD_ID|2041|hsp_num:0	2259			396	450	erythromycin; clarithromycin; azithromycin
BGC0000235.1|Kiamycin_8 # 5957 # 6664 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.701	BGC0000235.1|Kiamycin_8 	5957	6664	-	Loose	1280	30.0314	macB	60.0	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCACGACACTGATCACCGGCGCCAACAAGGGCCTCGGATACGAGACCGCCCGACGCCTGACCGAGGCGGGCCACACCGTCCTCCTCGGGGCACGCGACCCCCGGCGCGGGCGAGCGGCGGCCGAGCGGATCGGCGCCCGTTTTCTCCCGCTCGACGTGACCGGCGAGGAGTCCGTCCTGGCGGCAGCCGATCGCGTCCGTGAGGAGTTCGGGCACCTGGACGTCCTCGTCAACAACGCCGGAATCACCGGCCCCCGCAAGGAGGCCGCGGAGCTGACGGCCGACGACATCAAGAAGCTCTACGACACCAATGTGTTCGGAGCCGTCCGGGTCACCCGCGCGTTCCTGCCACTGCTCCGGGCCGGTGAGTCGCCCACCGTGGTGAACGTCAGCAGCGGACTGGGATCACTGGCCATCGCCGCCGAGCCCGAGCGCTTCGGGTCGCTGCTTCCCGTGTACTACCCGAGCCTGGGCTACAACTCCTCCAAGGCCGCCCTGAACATGATCACCGTGCAGTACGCGAAGGCCTTCCCGGAGATCACGTTCAACGCCGTGGACCCGGGCTGGACCGCCACCGACCTGAACGACCACCGGGGCGTCCAGACCGTCGAGGAGGGCGCCGCGGTGATCGTCCGGATGGCCACGCTCGGAGGCGACGGCCCCACCGGCGGCTTCTTCGGGAACACCGGCCCCGTCCCCTGGTGA	MTTTLITGANKGLGYETARRLTEAGHTVLLGARDPRRGRAAAERIGARFLPLDVTGEESVLAAADRVREEFGHLDVLVNNAGITGPRKEAAELTADDIKKLYDTNVFGAVRVTRAFLPLLRAGESPTVVNVSSGLGSLAIAAEPERFGSLLPVYYPSLGYNSSKAALNMITVQYAKAFPEITFNAVDPGWTATDLNDHRGVQTVEEGAAVIVRMATLGGDGPTGGFFGNTGPVPW	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	36.49	gnl|BL_ORD_ID|446|hsp_num:0	487			549	609	erythromycin
BGC0000235.1|Kiamycin_9 # 6755 # 7450 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000235.1|Kiamycin_9 	6755	7450	-	Loose	400	82.8037	MexL	36.68	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGGTTGACGCGGTACGATGGCGGCGTGAACGGAGCCAAGACCTCAAGCGCGAGCAGACGCGAGGCGCCGCGCGGGCGCATCGACAAGCGGCAGGCGATCCTCGAAGCCGCGTTCAGGACGTTCGCCCGTGAGGGGTACGGACAGTCCTGCGTACGGGAGATCGCGGCCGAGGCGGGCGTGGCCAAGCCCACCATCTACAACCACCTCGGGGACAAGGAGACGCTGTTCCGCGAGGCGATGCTGGCCGCCGTCGGCCGTACGAGCGGCGCGGGGCTCGGGGCGCTCGAACAGCTCCGGGAGCCTGACGGTGATGTGCGCCCCATGCTGGAGGAAGCCGGCCTCCGCATTCTGAAGAACCACTGCGACCCGGAGTCGCAGGCGCTGCGCTGGCTCCTCAACGCCGAAGCGGCGCGGTTTCCCGACCTGTTGGAGACCATCCAGCGCGAGGGCGCGCAGCGCCTCCACGACGCGCTCGCCGACCGCCTGGCACGCTTCGCGCTCTCCGGGCGCCTGCACACCAGCGACCCGGACCTGGCCGCCGAGCAGTTCCTCGCGCTGCTCACGGGCCCGATGGCGCTGCGCACCCGGCTCGGTACGCGCAAGGTGTCCGACGCCGAACTGCGTGCCGTGGGGCGGGCCGCGGTCGACACGTTCCTGCGCGCCTACTCTCCCCGGGCCGTGGACTCTCCGTAG	MRLTRYDGGVNGAKTSSASRREAPRGRIDKRQAILEAAFRTFAREGYGQSCVREIAAEAGVAKPTIYNHLGDKETLFREAMLAAVGRTSGAGLGALEQLREPDGDVRPMLEEAGLRILKNHCDPESQALRWLLNAEAARFPDLLETIQREGAQRLHDALADRLARFALSGRLHTSDPDLAAEQFLALLTGPMALRTRLGTRKVSDAELRAVGRAAVDTFLRAYSPRAVDSP	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	108.96	gnl|BL_ORD_ID|4690|hsp_num:0	2219			51	627	erythromycin; tetracycline; triclosan
BGC0000235.1|Kiamycin_10 # 7573 # 9039 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.717	BGC0000235.1|Kiamycin_10 	7573	9039	+	Loose	900	180.644	lmrB	27.94	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTCTCAAGTCAGAGATGACCGGCTGGATCCCGGGCTGTTACGGCTCATCGGGGTGACCCTGCTGGGCGGGATCATGGGGATCCTCGACAGCACGATGGTCACCGTCGCGGCCGACACCCTCGCGGCGGAGTTCAACACCTCGCTGAGTTCCATCAGTTGGGCCACGACCGGCTATCTGCTGGCGCTCACGGTCACCATCCCCATCACGAGCTGGGCGGTGGGCCGGTTCGGCGTCAGGAAGCTCTGGCTTTTCGGACTGGTGCTGTTCCTGGTCGGTTCGCTCGCCTCCGCCCTCGCCTGGAACGTGGAGAGCCTGGTCGCCTTCCGGGTCGTCCAGGGTGTGGGCGCCGGTGTCGTCGACCCGCTGGTCCTGGTGATCCTGGCCCGTGCGGCGGGCCCCAGCCGGGCGGGGCGCGTGATGGGCATGATGGGCGTGGTCCTGTCGCTCGGGCCGGTCCTCGGGCCCGTGCTGGGCGGGGTCGTGCTCGAATCCATGGGCTGGCGCTGGATGTTCTACATCAACCTGCCCATCGGGATCGTCGCGGTCCTGCTCGCGCTGCGGGTGATCCCGGTCGGCCCGCCCCTCAAGCGCGGGTCCGGGCCCCGTCTCGACATCGTCGGCGCCCTGTTGATGGCTCCCGGTCTCGCGGCGATCCTGCTCGCCCTCACGGAGGCGGGCGAGCGCGCCCGGTTCGCCGTGCCCTCCGTGCTCATCCCGCTGGCCCTGGGCGTCGCGCTGCTCGTCGGGTACGTGATCCACGCGCTGCGAGCCCGCCGCACCGAACCGCTGATCGACATCCGGCTGTTCAGCAGCCGCAGCTTCGCCGCGAGCGTGACCGTGCAGGGGCTCGTCGGACTGGCCACGTTCGCCGTCCTGTTCGCCCTGCCGCTCTACTATCAGGTGCTGCACGGACACGGCGCCCGCGCGGCCGGACTGCTGGTGGCGCCGCTGGGCCTGGGATCGGCGCTCGCCATGCCTCTCGCCGGCCGCCTCAGCGACCGGCTGGGAGCGCGCAATCTCGTACGCGGCGGAGCGGTCGTGGCGGCGCTCGCCTCGGTCGGCCTCACCCGTATCGGTGCGGACAGCGGTGAAGTCTGGTCCGTGCTGGCCGCGTTCGCCGTCGGCCTGGGCCTGGGCGGCGTCGGCGCGCCGACCATGGGTTCGCTGTACCGGACGCTGCCGCCGGAGAAGGTGCCGCAGGGCAGTTCCGTCGTCTACAACCTCAACCAGTTGGGCGGCGCGCTCGGGGTCGCGTGTGTCGCCCTGATCCTGGCGGCCGTCGGAAATGGCGCCGCGGCCGGCGGCGCCGGGATCGGTGGCTTCCACGGTGCGTACTGGTTCGTTTTCGCGGTCACCCTGGTGATTCTGGCCGCCTCTCCGCTGCTGCCCGGCCGCCCCGAGGCCCCGACCGCGGTGCAGGCCGAGGCGTCGTCCGCCGACGGCTCCGCCATGGCGCACCCATAG	MSQVRDDRLDPGLLRLIGVTLLGGIMGILDSTMVTVAADTLAAEFNTSLSSISWATTGYLLALTVTIPITSWAVGRFGVRKLWLFGLVLFLVGSLASALAWNVESLVAFRVVQGVGAGVVDPLVLVILARAAGPSRAGRVMGMMGVVLSLGPVLGPVLGGVVLESMGWRWMFYINLPIGIVAVLLALRVIPVGPPLKRGSGPRLDIVGALLMAPGLAAILLALTEAGERARFAVPSVLIPLALGVALLVGYVIHALRARRTEPLIDIRLFSSRSFAASVTVQGLVGLATFAVLFALPLYYQVLHGHGARAAGLLVAPLGLGSALAMPLAGRLSDRLGARNLVRGGAVVAALASVGLTRIGADSGEVWSVLAAFAVGLGLGGVGAPTMGSLYRTLPPEKVPQGSSVVYNLNQLGGALGVACVALILAAVGNGAAAGGAGIGGFHGAYWFVFAVTLVILAASPLLPGRPEAPTAVQAEASSADGSAMAHP	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	102.31	gnl|BL_ORD_ID|540|hsp_num:0	592			60	1269	
BGC0000235.1|Kiamycin_11 # 9208 # 10365 # 1 # ID=1_11;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.660	BGC0000235.1|Kiamycin_11 	9208	10365	+	Loose	1900	28.1054	MuxC	28.21	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAGCGGCTTTTGGTCGTTTCTTGGACGGCCGCTGCGAGGATCCACAGGACTCGGCAACCGAACCACGATCCGTTCGGATTCGGAGTCGTCCTGCTACTCCTTGGAGGGGCCTCGTATGAGCGACCAGAAGAATGCGGTTCCGGAGCCGGAAGAGCCATTTATCGGTCAGGTCATGGGACCGTTGACCGGATTCTGGCAGACGAAGATTCTGCTTACCGCCGTGGAATCCGGTCTCTTCACCGAATTGTCCGGTTCCTCGGCCACCGCCGAGGAACTGAGCACTCGGCTCGGGTACCGCATGCCGGGAGCCAGTGACTTCTTTCTGGCCCTCGCCGGGATGGGACTGCTGGACGCCTCGGAGGCCGGAGAGTTCCGTAACTCCCCTGCCGCCGACCGGTATCTGGTGCGCACCCGCCCGGAATTCATCGGCGGCTACCTCCAGTTCTGTGAGCGCGAGCTGAACCCGGCCTGGGAAGGTCTCGGGACGGCGCTACGCACGGGCGCCCCACAGAATCCCGCCGCGCTGGAGGGCAACCCGTACGAAACTCTCTACCAGGACCGGGAATCGACGGAATCGTTCCTGGAGAGCATGGACACACTCAACACGCCCCTCCTGCGGCGCCTGGGCGAGATCGACTGGAGCGGCTACGACTCGTTCGTGGACGTCGGCGGCGCGCGCGGCAACGTCGCCCACCATCTGGCGCTGAACAACCCGCATCTGAAGGGCGCGGTGTTCGATCTGCCGCAGTTGGAGGGGGCCTTCACCACCCACATGGCCGCCCTCGGCGACGACGGGGCGGTCTCGTTCCACGGCGGCGACTTCTTCGCCGGCCCGCTGCCCGAGTCCGATGTGCTCATCTTCGGTCATGTGCTCCACAACTGGGGTGTGGACGAGCGCCGCACGCTGCTGCGCAAGGCGCACGACGCGATCCGGCCGGGGGGAGCGGTCATCATCTACGACCCCATGGTCAGCAACAGCGCGCCACCGCTCTACGCGACGCTCGCCGCGCTGAGCATGCTGGTGTGGTCCGCGGGCGGCGGCGAGTACCCGGTCAGTGACTGCCACGCGTGGCTCGAAGAGGCCGGATTCCGCCCTGAGACGGTCGGTCCCGAGGACACACCGGACGACGTTCTGGTCATCGGGCGAAAGAGCTGA	MSGFWSFLGRPLRGSTGLGNRTTIRSDSESSCYSLEGPRMSDQKNAVPEPEEPFIGQVMGPLTGFWQTKILLTAVESGLFTELSGSSATAEELSTRLGYRMPGASDFFLALAGMGLLDASEAGEFRNSPAADRYLVRTRPEFIGGYLQFCERELNPAWEGLGTALRTGAPQNPAALEGNPYETLYQDRESTESFLESMDTLNTPLLRRLGEIDWSGYDSFVDVGGARGNVAHHLALNNPHLKGAVFDLPQLEGAFTTHMAALGDDGAVSFHGGDFFAGPLPESDVLIFGHVLHNWGVDERRTLLRKAHDAIRPGGAVIIYDPMVSNSAPPLYATLAALSMLVWSAGGGEYPVSDCHAWLEEAGFRPETVGPEDTPDDVLVIGRKS	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	37.16	gnl|BL_ORD_ID|2367|hsp_num:0	2720			315	540	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000235.1|Kiamycin_12 # 10461 # 11948 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.734	BGC0000235.1|Kiamycin_12 	10461	11948	+	Loose	550	308.916	Nocardia farcinica rox	42.6	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGTCGTGGGAGCGGGGCCGGCGGGTCTGATGCTCGCCGGAGAGCTGCGTCTGGCCGGGATCGATGTGGTGGTCCTGGACCGTCTCCCGCAGCGCACCGGAGAGTCCCGGGGCATCGGGCTCACCCCCCGCACCGTGGAAGTCCTGGACCAGCGTGGCCTGTTGCCGCGCTTCGGCGACATCGAGATGAGCAGCCTCGGGCACTTCGGCGGAATACCCCTGGATTTCGGTGTCCTGGGCGGTGGCGACCGGGCCGCCAGGACCGTGCCGCAGTCCGCCACCGAATCCGTACTGGAGAGCTGGGCCCGCGAACTCGGCGCGGACATCCGCCGCGACCACGAGTTCACCGGCCTGACGGACCACGGCGGCCATGTCGAGGCGCAGGTACGCGGCCCGGCGGGCCAACAGGTCCTGAGCTGCCGCTTTCTGGTCGGATGCGACGGGGGCCGCAGCGCCGTGCGCAAGGCCGCCGGCTTCGACTTCCCCGGCACCCCGGCCACCACCGAGCTCCTCCTCGCGGATATCCGGGGTGTCGATCTGGAGCCGCGCATGGTCGCCGACCGGGTCACCGACGGCATGGTCATGACCGCCCGGCTCGGGGACGGCGTCCACCGCGTCATCGTCGCCGAACGCGGTGCGCCGCCGCAGCGGAGGACGGGCCCGCCCGCCTTCGCCGAGGTCGCCGACGCCTGGAAGCGGCTCACCGGCATCGACATCTCGCACGCCGAACCCGTGTGGCTCAGCGCCTTCGGCGACGCCACGCGTCAGGTCACCGAGTACCGCCGCGGCAGGGTGCTGCTGGCCGGGGACTCCGCCCACATCCACCTCCCGGCCGGCGGACAGGGCATGAACACCAGCGTTCAGGACTCGGTGAACCTGGGCTGGAAACTCGCTGCCGTACTGCACGGCGCCGCCGGCCCCGCGCTGCTCGACACGTATCACACCGAACGCCACGAGGTCGGCCGTCGGCTCCTCGCCAACACCCGCGCCCAGAGCCTGCTGATCCTCGGCAGCGAGGAGGTGCAGCCGCTGCGCGACATCCTGACCGAGCTGGCGCGGTACGAGGAGGTCGCCCGCCACTTCGCGGCCAAGGCGGGGGGACTGGACATCCGCTACGACGTCGGGAGCGGCCCCAACCCCCTGCTGGGGATGCGGATGCCGCGGTTGGAGCTGTTGCGGGGCACCACCGTCACCTCCAGCACCGAGCTGCTCCGGGCCGGCCGGGGCGTGCTGCTCGACCTGGCCGATACGCCGCGGCTGCGGCGGCGCGCGGCCCCCTGGGCGGACCGTGTCGACCTGGTCACCGCCGCTCCCCGGGGCACTGCCGCCCTCGGCGGCGGGCTCGACGGGACGAGCGCCGTACTGCTGCGCCCCGACGGCCACGTCGCCTGGATCGCACCCGGCAGCCACCACGACCTGCCGATGGCCCTGGAGCGCTGGTTCGGCCCCGCCCGGCAGCACGGTACGGCGCACACACGCGCCGTATGA	MVVGAGPAGLMLAGELRLAGIDVVVLDRLPQRTGESRGIGLTPRTVEVLDQRGLLPRFGDIEMSSLGHFGGIPLDFGVLGGGDRAARTVPQSATESVLESWARELGADIRRDHEFTGLTDHGGHVEAQVRGPAGQQVLSCRFLVGCDGGRSAVRKAAGFDFPGTPATTELLLADIRGVDLEPRMVADRVTDGMVMTARLGDGVHRVIVAERGAPPQRRTGPPAFAEVADAWKRLTGIDISHAEPVWLSAFGDATRQVTEYRRGRVLLAGDSAHIHLPAGGQGMNTSVQDSVNLGWKLAAVLHGAAGPALLDTYHTERHEVGRRLLANTRAQSLLILGSEEVQPLRDILTELARYEEVARHFAAKAGGLDIRYDVGSGPNPLLGMRMPRLELLRGTTVTSSTELLRAGRGVLLDLADTPRLRRRAAPWADRVDLVTAAPRGTAALGGGLDGTSAVLLRPDGHVAWIAPGSHHDLPMALERWFGPARQHGTAHTRAV	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	104.65	gnl|BL_ORD_ID|4834|hsp_num:0	5821			12	1416	rifampin
BGC0000235.1|Kiamycin_13 # 11989 # 12315 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.657	BGC0000235.1|Kiamycin_13 	11989	12315	+	Loose	700	22.7126	MOX-9	32.65	3002191	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	ATGTACAGCACATTGATTGTCGCCCGGATGGAACCCGGTTCCGCCGGTGAGGTGGCCCGGCACTTCTCCGCCTTCGACGCTACGGAGATGCCGGAACTGATGGGAACGCGCCGGCGCGAGCTCTTCTCGTTCCGGGGGCTCTACTTCCACCTTCAGGATTTCGACGGTGAGAACGGCGGCGAGCGGATCGAACAGACGAAGGGGGACCCGCGGTTCGTCGGGATCAGCCAGGATCTGAAGCCGTTCATCGACGCGTACGACCCGGCGACCTGGCGCTCCCCCGCCGACGCGATGGCGCGGCGCTTCTACCACTGGAGCGCCGAGTGA	MYSTLIVARMEPGSAGEVARHFSAFDATEMPELMGTRRRELFSFRGLYFHLQDFDGENGGERIEQTKGDPRFVGISQDLKPFIDAYDPATWRSPADAMARRFYHWSAE	MQQQVRMTLLMASTLLWAGLAQATADTQADPLRPLVDASIRPVLKEHRIPGMAVAVLKDGKAHYFNYGVANRESGARVSEQTLFEIGSVSKTLTATLGAYAVVKGALKLDDKVSQHGPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSIDKMRAYYRQWTPAYRAGSHRQYSNPSIGLFGHLAAQSLGQPFEQLMSQTLLPGLGLEHTYLKVPAEAMANYAYGYSKEDKPIRVNPGVLADEAYGIKTSSADLLKFVGANMTGTGDEAMQQAIALTHKGVYSVGAMTQGLGWESYAYPVTEETLLAGNSGKVILEANPTAPASNETGSQVLFNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPIQARVETAHAILSKLAE	28.20	gnl|BL_ORD_ID|2100|hsp_num:0	2329			546	690	
BGC0000235.1|Kiamycin_14 # 12312 # 13592 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.713	BGC0000235.1|Kiamycin_14 	12312	13592	+	Loose	750	193.741	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	33.71	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGTGCCGTATACGGGCGCCAGGTCGTCATCACCGGGATCGGAGTCACGGCACCGGGCGGACCGGGGACGAAGGGGTTCTGGCAGCTCCTCACCGACGGCCGTACGGCCACCCGGCGGATCTCGTTCTTCGACCCCTCGCCCTTTCGCTCCCAGGTCGCCGCGGAAGTGGACTTCGACGCCGAGGCGTGCGGTCTCGGCCCGCAGGAGATCCGGCGCATGGACCGCGCCGCGCAGCTCGCGGTGGTCACGGCGCGCGAGGCGGCGGCCGACAGCGGGCTTGCCTTCCACACGCTGGATCCGGGCCGCATGGGGGTGACCATCGGCAGCGCCGTGGGCGCCACCATGGGTCTCGACGAGGAGTACCGGACGGTCAGCGACGGCGGCCGCCGGGAGCTGGTCGACCACGAGTACGCCGTTCCGCACCTCTACAACTACATGGTCCCCAGCTCCTTCGCCGCCGAGGTGGCCCACGCGATGGGTGCCGAGGGGCCCGCCTCGGTCGTCTCCACGGGATGCACATCCGGCCTGGACGCGGTCGGCTACGCCACCGAGGTGATCAGGGAGGGCACGGCGGACGTCATGATCGCCGGTGCGACGGAGGCGCCGATCTCACCGATCACCGTGGCCTGCTTCGACGCCATCAAGGCGACCACGCCGCGCAATGACGATCCCGCGCACGCCTCGCGGCCCTTCGACGCGAGCCGCAACGGCTTCGTCCTGGGCGAGGGCGCCGCCGTCTTCGTCCTGGAGGACGGGGAGAGCGCCCGGCGGCGCGGCGCCCATGTCTACGCGGAGGTGGCAGGCTACGCGACGCGCTCCAACGCCTTCCACATGACCGGACTGCGCCCCGACGGCAAGGAGATGGCGGAGGCGATCCGCATCGCCATAGCGGAGGCCCGCGTCAACCCGGAGGACATCGACTACATCAACGCCCACGGCTCGGGCACCAAGCAGAACGACCGCCATGAGACCGCGGCCTTCAAGCTGAGCCTGGGCGAGGCGGCGTACCGCACACCGGTCAGCTCCATCAAGTCCATGGTCGGCCACTCGCTCGGCGCGGTCGGCTCCATCGAGCTCGCCGCCTCCGCGCTGGCGATGGAGCACCACGTCATTCCGCCCACGGCCAATCTCCACACCCCGGACCCGGAGTGCGACCTGGACTACACGCCCCTCACCGCCAGGGAGCGGCGCACGGACACCGTGCTGTCGGTGGGCAGTGGCTTCGGCGGCTTCCAGAGCGCGGTGGTGCTGGCCCGGCCCGACAGGAGGAGGCGATGA	MSAVYGRQVVITGIGVTAPGGPGTKGFWQLLTDGRTATRRISFFDPSPFRSQVAAEVDFDAEACGLGPQEIRRMDRAAQLAVVTAREAAADSGLAFHTLDPGRMGVTIGSAVGATMGLDEEYRTVSDGGRRELVDHEYAVPHLYNYMVPSSFAAEVAHAMGAEGPASVVSTGCTSGLDAVGYATEVIREGTADVMIAGATEAPISPITVACFDAIKATTPRNDDPAHASRPFDASRNGFVLGEGAAVFVLEDGESARRRGAHVYAEVAGYATRSNAFHMTGLRPDGKEMAEAIRIAIAEARVNPEDIDYINAHGSGTKQNDRHETAAFKLSLGEAAYRTPVSSIKSMVGHSLGAVGSIELAASALAMEHHVIPPTANLHTPDPECDLDYTPLTARERRTDTVLSVGSGFGGFQSAVVLARPDRRRR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.40	gnl|BL_ORD_ID|1968|hsp_num:0	1943			213	1245	isoniazid
BGC0000235.1|Kiamycin_15 # 13475 # 15112 # -1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.718	BGC0000235.1|Kiamycin_15 	13475	15112	-	Loose	475	30.4166	PST-1	25.0	3006976	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	PST beta-lactamase	TTGCCCGTTGACGAGAGCGATCAGCGCACGCGGTGTGCGGGCGTCGGCGAAGATCTCCTCGTCGAGGCTGATCCCGTACTCCCGCTCGATACGGCCGGCGGTCTCCAGCATCGCCAGGGACTCGTAACCCAGCGCGTCGAACTCCGCGTCGAGAATGTCTCCGTCGAGGTCGACGCCCTCGTCGGCGCCGGCGCCCTCGCGCAGGATGGACTTGAGGTCGTCGATGGTGAAGGGGGTCGCGGGCATGAGGGTCCTTCCTCGAAACGCATGGGTGGAGGGCTTGCGCATTTCCGGGCCGGTGGATCAGTCGCGTGGTGCGCGCACCACGACCGCGGAGTTGAATCCGCCGTAGCCGCGGGCGAGTACGAGCGCGGTGCGCACGGGTGTCTCGCGCGGCGGGCCGGTCACCAGATCGATGTCGTAGTGAGGGGAGAGCGAGGTGTTGGTGGTCGGCGGGATGACGCCGTCCCTGATGCTGAGACAGGCGGTGGCCACGTCCAGCGGGGCGGCGCCCGAGTACAGTCGCCCGGTCATGGTCTTGGGTGCGGTCACGGGTACCGCCCGGGGGCCGAAGACCTTGCTGATCGCCTCGGCTTCGACCCGGTCGAGTTCCGGCACCGCGGCCGCGTCCGCGAACACCACGTCCACGTCGCCGGGCGCCGTTTCCCCGTCGCACAGCGCCTGTTCGACCGCCCGTCGCAGCCCCGGGCCGCGGTCGCCGCCCGGCGCGGGGTCGAAGGTGGAGGCATGGCCGGCGATCTCGGCGTACACCTGCCGTGCCCCGCGGGCGCGGGCGTGGTCGGCGTCCTCCAGGATGAGCAGCGCTCCGCCCTCTCCCGGTACGTGCCCCGCGGCGCCGTCGTCGAAGGGCACATAGGCCCGCCCGGGATCGGTGGCGCGGCTGAGCCGGCCGCTCGCGAGCTGGGCCACCCAGCCCCAGGGGCAGATCGAGGCGTCGATGGCCCCGGAGACGATCAGCGGTGTGCCCTTGCGGATCTGCCGGCGGGCCTGGGCCAGCGCGTCCAGACCGCCGGCCTGGTCGCTGACGACGACCCCGCTGGGGCCGCGCATACCGTTGCGGATCGAGATCTGGCCGCTGTTGACCGCGTAGAACCACGCGAAGGACTGGTACGCGCTCACATACCGGCCGCCCTTGCTCCACAGTGCCCGGAGTTCCTTCTGGCCGAACTCGAACCCGCCGGAATGACTGGCCGTGATGACACCCATGTCGTACGCGGGCAGGGTGTCCGGTACGACCCCCGCGTCCTCCAGCGCCCAGTCGGCGCTGACCAGCGCCAGCCGGGTCATCCGATCGGTCTGGGGCAGCAGCCGGCTGGGCAGGTGGTCCTCGGCGGTGAACCCGGCGATCTCCCCAGCCAGTTGAGCGGGATAGGACGTGGGGTCGAACCGGCCGACCCGGCCGATGGCGCCCCGGCCCGCCAGCACGGCCGACCAGTAGGACTCCAGACCCAGACCGTTGGGCGCCGCCACGCCGAGTCCCGTCACCACGGTGGTGGCGTTCATCGCCTCCTCCTGTCGGGCCGGGCCAGCACCACCGCGCTCTGGAAGCCGCCGAAGCCACTGCCCACCGACAGCACGGTGTCCGTGCGCCGCTCCCTGGCGGTGAGGGGCGTGTAG	MPVDESDQRTRCAGVGEDLLVEADPVLPLDTAGGLQHRQGLVTQRVELRVENVSVEVDALVGAGALAQDGLEVVDGEGGRGHEGPSSKRMGGGLAHFRAGGSVAWCAHHDRGVESAVAAGEYERGAHGCLARRAGHQIDVVVRGERGVGGRRDDAVPDAETGGGHVQRGGARVQSPGHGLGCGHGYRPGAEDLADRLGFDPVEFRHRGRVREHHVHVAGRRFPVAQRLFDRPSQPRAAVAARRGVEGGGMAGDLGVHLPCPAGAGVVGVLQDEQRSALSRYVPRGAVVEGHIGPPGIGGAAEPAARELGHPAPGADRGVDGPGDDQRCALADLPAGLGQRVQTAGLVADDDPAGAAHTVADRDLAAVDRVEPREGLVRAHIPAALAPQCPEFLLAELEPAGMTGRDDTHVVRGQGVRYDPRVLQRPVGADQRQPGHPIGLGQQPAGQVVLGGEPGDLPSQLSGIGRGVEPADPADGAPARQHGRPVGLQTQTVGRRHAESRHHGGGVHRLLLSGRASTTALWKPPKPLPTDSTVSVRRSLAVRGV	MKLLFAALFVVMFCGLARASDSLPELRIEKIAEGVYLHTSFQQVQGYGLVDANGLVVLDGQGAYIIDTPWSERDTAALVAWLQERNYQVKASVSTHFHDDRTAGIEYLNAISVPTYASARTNALLKQNGKALATETFDDAPLWLLEGKVEVFYPGAGHSVDNLVVWLPEQKLLNGGCFVRAAAAGTLGNTADAVVSEWAASAERLQRRYPDAQLVIPGHGVPGDVSLLEHTRKLALAATAKD	225.21	gnl|BL_ORD_ID|4563|hsp_num:0	5633			72	396	
BGC0000235.1|Kiamycin_16 # 15174 # 15959 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.681	BGC0000235.1|Kiamycin_16 	15174	15959	+	Loose	200	25.7942	sdrM	34.09	3007013	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGCAGGACATAGTGAAGGTCGCGCTTGTGACCGGTGCCACCAGCGGTATCGGCCTGGCCACCACCCGGCTGCTGGCCGGACAGGGCCACAAGGTCTTCCTGTGCGCGCGCACCGAGGACGACGTGTCGCGAACGGTCAAGGAACTTCGGGGCGAGGGACTGGAGGTGGACGGCAGGGCAGCGGACGTGTGCTCGAAGGACGACATCCGGGACCTGGTCCGGGCAGCCGTCGGCCGCTTCGGTCCCATCGACATCCTGGTGAACAACGCGGGCCGCAGCGGCGGCGGGGTCACCGCCGACATCGCCGACGAGCTGTGGTTCGACGTCATCAACACCAACCTCAACAGCGTCTTCCTCGTGACGCGCGAGGTGCTGACCACCGGCGGAATGCGCGACAGGCCCGGGGGACGCGTCATCAACATCGCGTCCACGGCCGGTAAACAGGGCGTCGTCCTGGGTGCGCCCTACTCCGCCTCCAAGCATGGTGTCGTCGGCTTCACCAAGGCGCTGGGCAACGAACTGGCCCCGACCGGCATCACCGTCAACGCCGTGTGCCCCGGCTATGTGGAGACCCCGATGGCGCAGCGGGTGCGCCAGGGCTACGCCGCCGCGTACGAGGTCGACGAAGAGCAGATCCTGGAGAAGTTCACCGCCAAGATCCCGCTCGGCCGCTACTCCACCGCGGAGGAGGTCGCCGGTCTGGTCGGCTACCTCACCTCCGACACCGCGGCGTCCATCACCGCGCAGGCGCTCAACGTCTGTGGCGGCCTCGGCAACTTCTGA	MTQDIVKVALVTGATSGIGLATTRLLAGQGHKVFLCARTEDDVSRTVKELRGEGLEVDGRAADVCSKDDIRDLVRAAVGRFGPIDILVNNAGRSGGGVTADIADELWFDVINTNLNSVFLVTREVLTTGGMRDRPGGRVINIASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPTGITVNAVCPGYVETPMAQRVRQGYAAAYEVDEEQILEKFTAKIPLGRYSTAEEVAGLVGYLTSDTAASITAQALNVCGGLGNF	MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE	58.39	gnl|BL_ORD_ID|4659|hsp_num:0	5729			291	408	norfloxacin
BGC0000235.1|Kiamycin_17 # 15995 # 16966 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.679	BGC0000235.1|Kiamycin_17 	15995	16966	+	Loose	500	26.5646	APH(3')-IVa	32.65	3002648	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGCCCACCACTGCCAAGGAGATGAACATGACCGAGCAGGCGCCCCGCGAAGTCGAGCACGAGATCACCGTGTCCGCCCCTGCCCCGGAGGTCTACCGCCTCCTCGCGGAGGTGGAGAACTGGCCAAGGATCTTCCCGCCGTCGGTGTACGTCGACTACGTGGAGAAGAACGGTGACGAGGAGCGCATCCGGATCTGGGCCACGGCCAACGGCGAGGCCAAGAACTGGACATCACGCCGCCGGCTCGACCCGGCGGGCCTGCGTATCACCTTCGGTCAGGAGGTTTCCGCGCCGCCGGTCGCCGAGATGAGCGGTACGTGGATCATCGAGCCACAGGGGGCGGGGTGCCGGCTGCGGCTGCTGCACTCCTACCGTGCCATCGACGACGATCCGGCGGGCCTGGCGTGGATCGACCGGGCCGTGGACCGCAACAGCCGCTCCGAACTCGCCGCGCTCAAGACGAATGTGGAGCTGGCCGCGCACTCCGCCGAGCTGACGCTGACCTTCGAGGACAGCGTACGGATCAACGGCTCGGCCAAGGACGCGTACGACTTCGTCAACGAGGCCCAGCTGTGGACCGATCGGCTGCCGCATGTCTCCCGGGTCTCGCTGACCGAGGACGAACCGGGAGTCCAGACCCTGCGCATGGACACGGTCGCGAAGGACGGCTCCACGCACACCACGGAGTCGGTCAGAGTGTGCTTCCCGCACCACGGGATCGTGTACAAGCAGACCACGCTGCCCGCCCTGATGACCCTGCACACCGGCAGCTGGCGGTTCGACGAGGGAAGTGACGGCGTCACCACCGCGACGTCCCGGCACACCGTGGTCATCAACACCGAGAACATCATGCGGATCCTCGGACCGGACGCCGGAATCCCGCAGGCCCGCACCTTCCTGCGTGAGGCGCTGGGAGCCAACAGCCGGGCGACGCTGGGGCATGCCAAGTCCTACGCGGAAGCGCGGCGCTGA	MPTTAKEMNMTEQAPREVEHEITVSAPAPEVYRLLAEVENWPRIFPPSVYVDYVEKNGDEERIRIWATANGEAKNWTSRRRLDPAGLRITFGQEVSAPPVAEMSGTWIIEPQGAGCRLRLLHSYRAIDDDPAGLAWIDRAVDRNSRSELAALKTNVELAAHSAELTLTFEDSVRINGSAKDAYDFVNEAQLWTDRLPHVSRVSLTEDEPGVQTLRMDTVAKDGSTHTTESVRVCFPHHGIVYKQTTLPALMTLHTGSWRFDEGSDGVTTATSRHTVVINTENIMRILGPDAGIPQARTFLREALGANSRATLGHAKSYAEARR	MNESTRNWPEELLELLGQTELTVNKIGYSGDHVYHVKEYRGTPAFLKIAPSVWWRTLRPEIEALAWLDGKLPVPKILYTAEHGGMDYLLMEALGGKDGSHETIQAKRKLFVKLYAEGLRSVHGLDIRECPLSNGLEKKLRDAKRIVDESLVDPADIKEEYDCTPEELYGLLLESKPVTEDLVFAHGDYCAPNLIIDGEKLSGFIDLGRAGVADRYQDISLAIRSLRHDYGDDRYKALFLELYGLDGLDEDKVRYYIRLDEFF	123.28	gnl|BL_ORD_ID|1156|hsp_num:0	1260			183	330	neomycin; ribostamycin; butirosin; kanamycin A; paromomycin
BGC0000235.1|Kiamycin_18 # 16970 # 18940 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726	BGC0000235.1|Kiamycin_18 	16970	18940	+	Loose	600	205.682	Streptomyces venezuelae rox	39.16	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGGCGGCTCAGCGGACGCCGACGTCCTCGTCGTCGGTGCCGGGCCCGTCGGGCTGCTGCTCGCGGGTGAGGTGAGCGCCGGCGGCGCCAGGACCGTCGTACTGGAGCAGTTGGCCGGGCCGACCGCCGAGTCCCGCGCCTCGATCCTCCACACGCGGACCATGGAGATCCTCGCCGAAAGGGGCATCCTCGACCGTTTGGGTGATCTCCCGGCCGGTGGGCGCGGCCATTTCGGCGGGATCCCGTTCGATCTGGCCGAGGCGGACCCGGGGCACCCCTACGCCGGCCAGTGGGAGTGCCTCCAGAGCCGCCTCGAACCCGTCCTGGAGGCATGGGCCGTGGAGCGGGGCGCCGAGGTACGCCGGGGGCACGTGGTCACCGGACTGACACAGCACGACGACCGGGTGGAGGTGGTGGCGTTCGGCCCCGGCGGAAGGAGCCACCGCCTCACGGCCGCCTATGTGGTGGGATGCGACGGGGAGCAGAGCACCGTACGCCGACTCGCGGGCTTCGCGATGACGGGCGACGACGCCACCAGGGAGATGCTCCGGGCCGACGTACTGGGCATCGACATCCCGGGCCGGCGCCTCAGACGGTACGCGGACGGCACCGCCACCGCCCACCGGCGCGGCGACGGGACCACCCGTCTCATGGTGCACGACCGCACCCGTGCACCCGGGCCTCGTACCCGCGAGCCCGAGTTCGCCGAGGTCGCCGCGGCGTGGGCCCGGGTGACGGGCGAGGACATCAGCGGCGGCACGGCGGTGTGGCTCAACAGCTTCGACGACACCCGGCGCCAGGCGCGGGACTACCGCCGAGGCCGGGTCCTTCTGGCGGGGGACGCCGCCCATGTCCAGATGCCCGTCGGCGGACAGGCACTCAACCTCGGGCTCCAGGACGCGGCCGGACTCGGCCGGAGGCTGGCGGCCCGCATCACCGGCGGGACGGGCGACGGCGGTCTGGACGAATACCACACGGAGCGCCATGCCGCGGGCACCCGCACCCTGACCAACATCCAGGCCCAGGCGCTGCTGCTGTTCGGCGGGCCCGAGGTGGACGGCATCCGCGAGGTGTGCGGCGAGCTCCTCGGCATGGACGTCGTCCGCCGCCACCTCGCCCGGACGATCAGCGGCCTGGACCGGCCGGCCCCACCGCCCGCGGCGGACACCACTCCACCCCTCTCAGCACACGGGAGTCCCACCATGGACAGGCTCACTGGAAAGACGGCGCTGGTCACCGGCTCCAGCCGGGGCATCGGCCGCGCCACGGCCGTACGGCTGGCCCGCGAAGGCGCCCTGGTCGCCGTGCACTACGCCACCAACGACGAAGCGGCGCTGGAGACCGTCGCCCTGATCGAGAAGGAGGGCGGCCGGGCCTTTCCGGTCCGCGCCGAACTCGGCGTCCCCGGGGATGTGCACGAGCTCTTCTTCGGCCTGGAGCAGGGGCTGAAGGAGCGGACCGGGGAAACCGCACTCGACATCGTGGTGAACAACGCCGCGGTGACGGGCTCGGACGGCATCAGCCCCGAGGACGTCACCCCGGAGCAGCTCGACCGCTACTTCGCGGTGAACGCACGGGCGCCGTACCTCGTCATCCAGCGGGCACTGCGGAACATGCCCGACGGGGGGCGCGTCATCAACATCTCCACCGCGCTCACCCGCACCGCGGTGCCCGAGCAGGTCGCCTATGCGATGACCAAGGGGGCCATCGAGCAGATCTCGCTGCACCTGGCGAAGCATCTGGCGCCGCGCGGGATCACCGTCAACAGTGTGGCGCCGGGGATCACGGACAACGGCGGGCCGGTCTTCGACATCCCCGAGGCCGTCGAGCAGATGGCGCAGGTCTCCGCGTTCAAGCGGGTGGGTGACGCCGGGGATGTCGCCGACGTGGTGACCTTCCTGGCCACCGACGAGGCGCGCTGGATCACGGGTTCGTTCATCGACGCCAGCGGCGGGACGCTCCTCGGATGA	MGGSADADVLVVGAGPVGLLLAGEVSAGGARTVVLEQLAGPTAESRASILHTRTMEILAERGILDRLGDLPAGGRGHFGGIPFDLAEADPGHPYAGQWECLQSRLEPVLEAWAVERGAEVRRGHVVTGLTQHDDRVEVVAFGPGGRSHRLTAAYVVGCDGEQSTVRRLAGFAMTGDDATREMLRADVLGIDIPGRRLRRYADGTATAHRRGDGTTRLMVHDRTRAPGPRTREPEFAEVAAAWARVTGEDISGGTAVWLNSFDDTRRQARDYRRGRVLLAGDAAHVQMPVGGQALNLGLQDAAGLGRRLAARITGGTGDGGLDEYHTERHAAGTRTLTNIQAQALLLFGGPEVDGIREVCGELLGMDVVRRHLARTISGLDRPAPPPAADTTPPLSAHGSPTMDRLTGKTALVTGSSRGIGRATAVRLAREGALVAVHYATNDEAALETVALIEKEGGRAFPVRAELGVPGDVHELFFGLEQGLKERTGETALDIVVNNAAVTGSDGISPEDVTPEQLDRYFAVNARAPYLVIQRALRNMPDGGRVINISTALTRTAVPEQVAYAMTKGAIEQISLHLAKHLAPRGITVNSVAPGITDNGGPVFDIPEAVEQMAQVSAFKRVGDAGDVADVVTFLATDEARWITGSFIDASGGTLLG	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	137.82	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1125	rifampin; rifaximin; rifapentine
BGC0000235.1|Kiamycin_19 # 18978 # 19742 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.693	BGC0000235.1|Kiamycin_19 	18978	19742	+	Loose	800	28.8758	efmA	30.0	3003954	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCTCCGACAGTCCCCGTATCACGCTCGTCACCGGCGCCAACAAGGGAATCGGACGCGCCGTCGTCCGGCGCCTCGGCGAGCTGGGCCAGCGTGTCTATCTGGGCGCCCGGGACGTGGAGCGGGGCAGGAACGCCGAGCGTGAGCTGCGTGCCGAGGGACTCGATGTCCGCTTCGTACAGCTCGATGTCACGGACGAGTCCTCGGTGGCCCTCGCCGCCAAGCGCATCGAGGAGGAGACGGGCCACCTGGACGCCCTGGTCAACAACGCGGGGACGGGCGCGCCGGTACGCGCGCCCAGCCGGACGCCGGCCAGTGTGGTGCGCCGCACCTATGAGACCAATGTGTTCGGTGTCATCACCGTCATCAACACGATGCTGCCGCTGCTGCGCCGCTCGCGGGCCGCCCGCATCGTCAACGTCAGCAGTGTGGTCGGATCCCTGACCCATGCCGCGGCCCTGGACGATCCCACCGGGGAGTTCCCCAAGGGGACGTACCCGGCGGTGCTGGACTACGGCACGTCGAAGGCGGCGCTGAACGCCGTCACCATCACCTACGCCAACGAGCTGCGCCCGGAGCGGATTCTGGTCAACGCCGTCTCACCCGGGTTCTGTTCGACCGATATCAACGGCCACCAGGGTCATCTGACGCCGGAGCAGGGGGCGCGTATCCCCGTACTCCTGGCGACTCTGGGCGACGACGGCCCGACGGCCGTCTTCCTGGGCGAGGACGGCTCCCCGACCGGTCAGCGGCTGGCATGGTGA	MTSDSPRITLVTGANKGIGRAVVRRLGELGQRVYLGARDVERGRNAERELRAEGLDVRFVQLDVTDESSVALAAKRIEEETGHLDALVNNAGTGAPVRAPSRTPASVVRRTYETNVFGVITVINTMLPLLRRSRAARIVNVSSVVGSLTHAAALDDPTGEFPKGTYPAVLDYGTSKAALNAVTITYANELRPERILVNAVSPGFCSTDINGHQGHLTPEQGARIPVLLATLGDDGPTAVFLGEDGSPTGQRLAW	MENEQSVVLTNWKRNYLFFLSGQFLSGITSMVVQYAIIWYLTRETGSATILSFATLLGMIPMVLLSPFVGPLVDRWDKKALLIVTDIIVAIFALILAVVGTISESFPIWLVFVSLFMRSVAQTFQMPTIQSIMPTIVPSSHITRTNGQLGMVQSANFIIAPALGAALFSVVPVNYLILLDVLGAVFGVGLLIFVKIPKVSPEILEVPLTIFKDAKFGLQQLMDNKGLWYITINGAFVMLLFMPAISLYPLMTLDYFGGSVGQAGAVEVVYAVGMLLGGALISFIGTWKDRMKPIIIAYIIMGLTIGASGLVPNDSQGFLYFLILNAGAGCATPYFNTLLMAMIQQSYESNVLGRVLGNFNSLMNLAGPIGLLFAGPLADRLGVEKMFLFSGIGILLCGIVLFLTSAARNYDKELQKKLVKEHHEQKDE	59.35	gnl|BL_ORD_ID|2187|hsp_num:0	2426			939	1059	erythromycin
BGC0000235.1|Kiamycin_20 # 19736 # 21325 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000235.1|Kiamycin_20 	19736	21325	+	Loose	700	27.335	DHA-3	40.54	3002134	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGGTGACGACCGTGGTCCGAGTGGACGGACCGAGCGAACCGACCGACCTGGACGACCTGGGCGAGCTGGGCGAGCGGAAGAGGCTCGCCGAGCAGGGGCCGGACCCCCGGGCCACCGAGCGGCAGCATGCCAAGGGCAAACTGACCGCCCGGGAACGGATCGCCCTCCTCCTCGACAAGGGCAGCTTCACCGAGGTCGAGGCGCTGCGCCGGCACCGGGCGAGCGGCTTCGGGCTGGAGGCGAAGCGCCCCTACACCGACGGCGTGGTGACGGGCTGGGGAACGGTCGAGGGCCGGACGGTCTTCGTCTACGCCCACGACTTCCGGATCTTCGGCGGGGCGCTGGGCGAAGCCCATGCCCAGAAGATCCACAAGATCATGGACCTGGCCGTCGCGGCGGGCGCCCCGCTCGTGTCGCTCAACGACGGTGCCGGGGCCCGTATCCAGGAAGGAGTCTCCGCCCTCGCGGGCTACGGGGGCATCTTCAGCCGCAACACCCGGGCATCCGGGGTCATCCCGCAGATCAGTGTGATGCTGGGACCGTGTGCGGGCGGCGCCGCCTACTCCCCGGCGCTCACCGACTTCGTCTTCGCGGTCCGCGGGATCTCGCAGATGTTCATCACCGGCCCCGATGTCGTGCAGGCCGTGACGGGCGAGGAGATATCGCAGGACGGCCTGGGCGGCGCGGATGTCCACGCCGGTGTCTCGGGCGTGGCCCACTTCGTGTACGACGACGAGGAGACCTGCCTGGCGGAGGTGCGCTTTCTGCTCTGCCTGCTGCCCGCCAACAACCGCGAACTGCCACCCGTCGCACCCGGCGTGGACCGGGCGGACCGGCTGTGCGATGCGTTGCCCGGACTCGTTCCCGACGAGGCCGGCCACTCCTACGACATACGCGCGGTGATCGAGGAACTCGTCGACGAGGGCGAGCACATGGAGGTCCACGCCGTGTGGGCGCCCAATCTCGTGTGCTCGCTGGCCCGGCTGGACGGCCAGGTGGTGGGCATCGTCGCCAATCAGCCCGCCGCGATGGCCGGCGTACTGGACATCACGGCGTCCGAGAAGGGCGCGCGCTTCGTCCAGTTCTGCGACGCCTTCAACATTCCCCTCGTCACCCTCGTCGATGTGCCCGGGTTCCTCCCGGGCGTGCGGCAGGAGCACGAGGGGATCATCCGGCGCGGTGCGAAGCTGCTGTACGCGTACTGCAACGCGACGGTGCCCCGGATCTCGGTGGTCCTGCGCAAGGCCTACGGCGGCGCCTACATCGTGATGGACTCCCGCTCGATCGGTGCGGACATCGCGCTGGCCTGGCCGGGGAACGAGATCGCCGTGATGGGCGCGGAGGGCGCCGCCAATGTGGTCTTCCGGCGGGAGATCGCCGCCGCCGAGGACCCGGAGGAGACGCGCCGCCAAAAGATCGAGGATTACAAGCGGGAGCTGGTGCACCCGTTCTACGCGGCCGAACGCGGCCTGGTCGACGATGTCATCGATCCGCGGGAGACCCGCTCGGTGCTGATCCGCTCGCTCTCCATGCTGCGGACGAAGGACTCCGGTCTGCCGCGCCGCAAGCACGGAAACCCGCCGCAGTGA	MVTTVVRVDGPSEPTDLDDLGELGERKRLAEQGPDPRATERQHAKGKLTARERIALLLDKGSFTEVEALRRHRASGFGLEAKRPYTDGVVTGWGTVEGRTVFVYAHDFRIFGGALGEAHAQKIHKIMDLAVAAGAPLVSLNDGAGARIQEGVSALAGYGGIFSRNTRASGVIPQISVMLGPCAGGAAYSPALTDFVFAVRGISQMFITGPDVVQAVTGEEISQDGLGGADVHAGVSGVAHFVYDDEETCLAEVRFLLCLLPANNRELPPVAPGVDRADRLCDALPGLVPDEAGHSYDIRAVIEELVDEGEHMEVHAVWAPNLVCSLARLDGQVVGIVANQPAAMAGVLDITASEKGARFVQFCDAFNIPLVTLVDVPGFLPGVRQEHEGIIRRGAKLLYAYCNATVPRISVVLRKAYGGAYIVMDSRSIGADIALAWPGNEIAVMGAEGAANVVFRREIAAAEDPEETRRQKIEDYKRELVHPFYAAERGLVDDVIDPRETRSVLIRSLSMLRTKDSGLPRRKHGNPPQ	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPDSAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNIEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	139.58	gnl|BL_ORD_ID|1856|hsp_num:0	2015			537	648	
BGC0000235.1|Kiamycin_5 # 3551 # 4714 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.668	BGC0000235.1|Kiamycin_5 	3551	4714	-	Loose	450	27.7202	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	27.84	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGGGCAGGATCGATGGGATCGCCCGAATGTCCGTTCCGGAGCCGCTCACCAGGGGAGCCCTGATCGGGTCTTATATGAGACGCCCGCACTCTCTCGGTACGAACGTTCTCCACATGAAAGGACCCTTCGAATTAGGACAGTCTGACGTGATGTCGCCCATTGTGAGATCGACCACACCTGCTCTCCCTCGCTCCGGTCGTCCGGCCCGACGCTGTCAATCTTCACGCAGATTTCGAAGAGCCGCGGCTGCCGGGCGCTCAGCGGCTCTGCCAGAATCGGCTGTGCCCACAGCTGGGTTGAATACGCGATGCGTTATTCCCCGGGCAGGTCCAGTCGTTGACGATGTTCTGGAGATGCAAATGACCAACACACGGCGAATTGTGCTGATCAGTGGAGCCGGCCGAGGCATCGGAGCCGCGACCGCACGTGAATTCGGGCGACGTGGCTGCCATGTGATCGTCAACTATCTGAGCAATAGCGAAGCCGCCGCGGTCGTGGTCAAGGACATCACGTCCGCGGGCGGCACCGCGCAGGCCGTACGCGCCGATGTCTGTGACGCGGGCCAGGTCGGCACACTGGTCGACGGAGTGCTGGCGGAGCACGGACGGGTCGATGTGCTGGTGTGCAACGCCAATACCGCCGCGCCGCCGTACGGTCCGTTCGCCTCGCTGCCCTGGGAGTCCTTCGCCGCCAAGCTCACCGGGGAGCTGGCCGGCGTCTACTTCCTGACGCAGCGGGTACTGGCGGCCATGCGGGAGCAGCGCGCGGGCCGGATCGTCTACGTGTCGAGCACCGCCGCCGATGTGATCACCGGAAGCATCGCCCATTCCACCGCCACCGCGGCGCTCAACACGTTCAGCCGGCAGATCGCCGCCGAGGCCGCCCAGTACGGGGTCGCGGCCAACACCGTCGCCCCGGGCGCGACCAACACCGATGCCACGGCCTTCTTCCCCGAGGCCATTCGGCAGTACTTCGGTGAGCGCTCCGTGCACGGCAGGCTGCCCGAACCCGAGGATGTCGGCCGGCTGATCGCCCTGGTCGCCGACGACGGGTTCGCCGGGGCGACCGGTCAGGTGTTCCGGGCCGACGACGGCTTCGATCTGCTCACCCAGCAACTCGACGGCCCGGCAGCCCGGTTCGGCGGCTCCGCCGCCCAGGACTGA	MGRIDGIARMSVPEPLTRGALIGSYMRRPHSLGTNVLHMKGPFELGQSDVMSPIVRSTTPALPRSGRPARRCQSSRRFRRAAAAGRSAALPESAVPTAGLNTRCVIPRAGPVVDDVLEMQMTNTRRIVLISGAGRGIGAATAREFGRRGCHVIVNYLSNSEAAAVVVKDITSAGGTAQAVRADVCDAGQVGTLVDGVLAEHGRVDVLVCNANTAAPPYGPFASLPWESFAAKLTGELAGVYFLTQRVLAAMREQRAGRIVYVSSTAADVITGSIAHSTATAALNTFSRQIAAEAAQYGVAANTVAPGATNTDATAFFPEAIRQYFGERSVHGRLPEPEDVGRLIALVADDGFAGATGQVFRADDGFDLLTQQLDGPAARFGGSAAQD	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	147.71	gnl|BL_ORD_ID|4712|hsp_num:0	2666			483	759	triclosan
